News

MyChesCo on MSN19m
FDA Approves Monjuvi for Treating Relapsed or Refractory Follicular Lymphoma
The U.S. Food and Drug Administration (FDA) has approved Monjuvi® (tafasitamab-cxix) in combination with rituximab and ...